Other Information
+Added: Trading Arrangements
+Added: On September 19, 2024, Marc Glickman,
+Added: our Chief Medical Officer, entered into a pre-arranged trading plan (the “10b5-1 plan”) that is intended to satisfy the affirmative
+Added: defense of Rule 10b5-1(c) under the Exchange Act.
+Added: Under the 10b5-1 plan, Mr.
+Added: Glickman can sell up to 653,526 shares of our common stock
+Added: between December 19, 2024 and December 31, 2025, subject to price and trading limitations under the plan.
following is a complete list of exhibits filed as part of this Form 10-Q.
11 unchanged sentences
Page Interactive Data File (embedded within the Inline XBRL document)
−Removed: and not filed herewith.
+Added: These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed
+Added: not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference
+Added: in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
−Removed: July 31, 2024
+Added: October 30, 2024
MEDICAL CORPORATION
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.